The 2010 Shanghai Auto Parts Exhibition officially ended on June 23, but the participating parts suppliers have recently issued a request for assistance to the Chinese government. The suppliers hope that the government can carry out the development of new energy vehicles business. Economic assistance.

Most parts suppliers stated that as more and more new energy vehicles continue to be developed and marketed, the market demand for automotive spare parts will gradually expand, but they are concerned that they cannot afford to be brought about by the large-scale commercialization of this green technology. The high technical cost.

An account manager of Shanghai Valeo Automotive Electrical Systems Co., Ltd. said: "The market demand for new energy vehicles will continue to grow next year, but many parts and components companies cannot afford the cost of product development alone. Without government funding, green energy technologies R&D will be greatly reduced."

Given that the Chinese government has provided subsidies to vehicle manufacturers in the area of ​​new energy vehicles, component suppliers have now offered corresponding financial assistance. However, industry analysts said that the government is unlikely to provide financial assistance to suppliers. Because China's spare parts industry is still very fragmented and lacks uniform quality standards.

[Composition]

The main component of this preparation is human immunoglobulin, which is prepared by cold ethanol fractionation of human plasma from healthy donors. The manufacturing process contains a step to remove anticomplementary activity and a dual viral inactivation process. It contains a suitable amount of glucose or maltose as stabilizer (see table below), but does not contain any antiseptic or antibiotic. The distribution of IgG subclasses is close to the serum level of normal subjects and maintains the bioactivity of Fc fragment of IgG.

[Indications]

1. Primary agammaglobulinemia, such as X-linked hypogammaglobulinemia, common variant immunodeficiency diseases, immunoglobulin G subclass deficiency, etc.

2. Secondary immunoglobulin deficiency diseases, such as severe infection, septicemia of newborn, etc

Intravenous Injection Of Human Immunoglobulin

Intravenous Injection Of Human Immunoglobulin,Intravenous Immunoglobulin,High-Quality Effective Intravenous Immunoglobulin,Human Immunoglobulin For Intravenous Injection

Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. , https://www.syimmunoglobulin.com